Loading
Latest filing published 20 Mar 2026 for Xvivo Perfusion Aktiebolag, €5,041.
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Kristoffer Nordström in Xvivo Perfusion Aktiebolag. The record holds 14 filings, for trades running from 31 May 2021 to 20 March 2026.
On the open market, the record shows 4 purchases worth €17k and 3 sales worth €71k. The net balance comes to €55k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and no sales.
A typical purchase (the median) is worth €3,487. Of 4 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 4 purchases show a median change of +2.0%, with the price up in 50% of them. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 20 March 2026 with an open-market purchase (€5,041) in Xvivo Perfusion Aktiebolag. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations